What is the ticker symbol for Aceragen?

Aceragen trades under the ticker ACGN on NASDAQ.

What sector does Aceragen operate in?

Aceragen is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ACGN in a portfolio?

PortView shows ACGN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Aceragen (ACGN) Stock Analysis

NASDAQHealthcareBiotechnology

$0.38+1.29%

1-year price historyRange $0.38 – $12.07

52-week range$0.38

$0.36$16.00

What Aceragen does

Aceragen, Inc., a biopharmaceutical firm in its clinical development phase, operates out of Exton, Pennsylvania, and was founded in 1989. The company, which transitioned from Idera Pharmaceuticals, Inc. and adopted its current name in January 2023, concentrates on the discovery, advancement, and bringing to market of therapeutic agents for uncommon lung and autoimmune conditions exclusively within the United States. Its product development pipeline includes ACG-701, currently undergoing Phase 2 clinical evaluation for both cystic fibrosis pulmonary exacerbations and melioidosis, as well as ACG-801, which is being developed to address Farber disease. Moreover, Aceragen maintains a partnership and option agreement with Scriptr Global, Inc. This collaboration aims to pinpoint, research, and cultivate gene therapy options intended for the management, palliation, diagnosis, or prevention of myotonic dystrophy type 1 and Friedreich's Ataxia.

Key metrics

Market cap

$3.24M

P/E (TTM)

-0.04

EPS (TTM)

$-8.60

Beta

1.14

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.16

200-day avg

$3.52

52-week high

$16.00

52-week low

$0.36

CEO

John C. Taylor

ETFs linked to ACGN

Broad-market and Healthcare sector ETFs an investor holding Aceragen is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ACGN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ACGN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Aceragen?: Aceragen trades under the ticker ACGN on NASDAQ.
Which exchange is ACGN listed on?: ACGN is listed on NASDAQ.
What sector does Aceragen operate in?: Aceragen is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ACGN in a portfolio?: PortView shows ACGN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.